{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:45:50Z","timestamp":1776134750894,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1R01HD094380"],"award-info":[{"award-number":["1R01HD094380"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s43032-021-00618-y","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T17:03:22Z","timestamp":1621357402000},"page":"3285-3288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Future of Uterine Fibroid Management: a More Preventive and Personalized Paradigm"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7556-2900","authenticated-orcid":false,"given":"Malak","family":"El Sabeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0554-132X","authenticated-orcid":false,"given":"Mostafa A.","family":"Borahay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"issue":"1","key":"618_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.fertnstert.2019.10.015","volume":"113","author":"M Ali","year":"2020","unstructured":"Ali M, Prince L, Al-Hendy A. Vitamin D and uterine fibroids: preclinical evidence is in; time for an overdue clinical study! Fertil Steril. 2020;113(1):89\u201390. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.10.015.","journal-title":"Fertil Steril"},{"issue":"7","key":"618_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41401-018-0184-6","volume":"40","author":"M Ali","year":"2019","unstructured":"Ali M, Shahin SM, Sabri NA, Al-Hendy A, Yang Q. Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment. Acta Pharmacol Sin. 2019;40(7):957\u201370. https:\/\/doi.org\/10.1038\/s41401-018-0184-6.","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"618_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/OGX.0000000000000718","volume":"74","author":"A AlAshqar","year":"2019","unstructured":"AlAshqar A, Patzkowsky K, Afrin S, Wild R, Taylor HS, Borahay MA. Cardiometabolic risk factors and benign gynecologic disorders. Obstet Gynecol Surv. 2019;74(11):661\u201373. https:\/\/doi.org\/10.1097\/OGX.0000000000000718.","journal-title":"Obstet Gynecol Surv"},{"key":"618_CR4","doi-asserted-by":"publisher","first-page":"733.e1","DOI":"10.1016\/j.ajog.2020.05.012","volume":"223","author":"S Afrin","year":"2020","unstructured":"Afrin S, Islam MS, Patzkowsky K, Malik M, Catherino WH, Segars JH, et al. Simvastatin ameliorates altered mechanotransduction in uterine leiomyoma cells. Am J Obstet Gynecol. 2020;223:733.e1\u2013733.e14. https:\/\/doi.org\/10.1016\/j.ajog.2020.05.012.","journal-title":"Am J Obstet Gynecol"},{"key":"618_CR5","doi-asserted-by":"publisher","first-page":"35075","DOI":"10.1074\/jbc.M114.583575","volume":"289","author":"MA Borahay","year":"2014","unstructured":"Borahay MA, Kilic GS, Yallampalli C, Snyder RR, Hankins GD, Al-Hendy A, et al. Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells. J Biol Chem. 2014;289:35075\u201386. https:\/\/doi.org\/10.1074\/jbc.M114.583575.","journal-title":"J Biol Chem"},{"key":"618_CR6","doi-asserted-by":"publisher","first-page":"196.e1","DOI":"10.1016\/j.ajog.2015.03.055","volume":"213","author":"MA Borahay","year":"2015","unstructured":"Borahay MA, Vincent K, Motamedi M, Sbrana E, Kilic GS, Al-Hendy A, et al. Novel effects of simvastatin on uterine fibroids: in vitro and patient-derived xenograft mouse model study. Am J Obstet Gynecol. 2015;213:196.e1\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2015.03.055.","journal-title":"Am J Obstet Gynecol"},{"key":"618_CR7","doi-asserted-by":"publisher","first-page":"750.e1","DOI":"10.1016\/j.ajog.2016.06.036","volume":"215","author":"MA Borahay","year":"2016","unstructured":"Borahay MA, Fang X, Baillargeon JG, Kilic GS, Boehning DF, Kuo YF. Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study. Am J Obstet Gynecol. 2016;215:750.e1\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2016.06.036.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"618_CR8","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.fertnstert.2018.07.024","volume":"110","author":"M Malik","year":"2018","unstructured":"Malik M, Britten J, Borahay M, Segars J, Catherino WH. Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production. Fertil Steril. 2018;110(7):1398\u2013407 e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.07.024.","journal-title":"Fertil Steril"},{"key":"618_CR9","doi-asserted-by":"publisher","first-page":"e650","DOI":"10.1210\/clinem\/dgaa718","volume":"106","author":"NM Fischer","year":"2020","unstructured":"Fischer NM, Nieuwenhuis TO, Singh B, Yenokyan G, Segars JH. Angiotensin-converting enzyme inhibitors reduce uterine fibroid incidence in hypertensive women. J Clin Endocrinol Metab. 2020;106:e650\u20139. https:\/\/doi.org\/10.1210\/clinem\/dgaa718.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"618_CR10","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.fertnstert.2012.10.048","volume":"99","author":"G Levy","year":"2013","unstructured":"Levy G, Hill MJ, Plowden TC, Catherino WH, Armstrong AY. Biomarkers in uterine leiomyoma. Fertil Steril. 2013;99(4):1146\u201352. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.10.048.","journal-title":"Fertil Steril"},{"issue":"11","key":"618_CR11","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1161\/CIR.0000000000000677","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e563\u2013e95. https:\/\/doi.org\/10.1161\/CIR.0000000000000677.","journal-title":"Circulation."},{"issue":"1","key":"618_CR12","doi-asserted-by":"publisher","first-page":"79 e1","DOI":"10.1016\/j.ajog.2020.03.022","volume":"223","author":"LW Rice","year":"2020","unstructured":"Rice LW, Cedars MI, Sadovsky Y, Siddiqui NY, Teal SB, Wright JD, et al. Increasing NIH funding for academic departments of obstetrics and gynecology: a call to action. Am J Obstet Gynecol. 2020;223(1):79 e1\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2020.03.022.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-021-00618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-021-00618-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-021-00618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T23:59:57Z","timestamp":1634687997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-021-00618-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1007\/s43032-021-00618-y","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"N\/A","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}